Effect of picrotoxin on antinociception in the formalin test

Pharmacology and Toxicology

Volumn 78, Issue 5, 1996, Pages 313-316

  Heidari, M R ^a   Khalili, F ^a   Ghazi khansari, M ^a   Hashemi, B ^a   Zarrindast, M R ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ATROPINE; FORMALDEHYDE; MUSCARINIC RECEPTOR BLOCKING AGENT; NALOXONE; OPIATE ANTAGONIST; PHACLOFEN; PHENOXYBENZAMINE; PICROTOXIN; POSTSYNAPTIC RECEPTOR; PROPRANOLOL; SULPIRIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; DRUG MECHANISM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0029973029     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1996.tb01381.x     Document Type: Article

References (19)

1. Bonanno, G. P., G. C. Cavazzani, A. D. Andrrioli, A. G. Pellegrini & M. Raiteri: Release-regulating autoreceptors of the GABA-B type in human cerebral cortex. Brit. J. Pharmacol. 1989, 96, 341-346.
2. Bowery, N. G.: Baclofen: 10 years on. Trends Pharmacol. Sci. 1982, 3, 400-403.
3. Desarmenien, M., P. Felz, G. Occhipinti, F. Santangeto & R. Schlicher: Coexistence of GABA-A and GABA-B receptors on AS and C primary afferents. Brit. J. Pharmacol. 1984, 81, 327-333.
4. Di Chihara, G., M. L. Porceddu, L. Vargiu, A. Argiolas & G. L. Gessa: Evidence for dopamine receptor mediating sedation in the mouse brain. nature 1976, 264, 564-567.
5. Dubuisson, D. & S. G. Dennis: The formalin test: quantitative study of the analgesic effects of morphine, meperidine and brain stem stimulation in rats and cats. Pain 1977, 4, 161-174.
6. Dunlap, K.: Functional and pharmacological differences between two types of GABA receptor on embryonic chick sensory neurons of clonidine. Neurosci. Lett. 1984, 47, 265-270.
7. Hyttel, J.: Functional evidence for selective dopamine D1 receptor blockade by SCH 23390. Neuropharmacology 1984, 23, 1395-1401.
8. Kerr, D. I. B., J. Ong, R. H. Prager, B. D. Gynther & D. R. Curtis: Phaclofen: a peripheral and central baclofen antagonist. Brain Res. 1987, 405, 150-154.
9. Kocher, L.: Systemic naloxone does not affect pain-related behaviour in formalin test in rat. Physiol. Behav. 1988, 43, 265-268.
10. Mitchell, P. R. & I. L. Martin: Is GABA release modulated by presynaptic receptors? Nature 1978, 274, 904-905.
11. Sawynok, J.: GABAergic mechanism of enalgesia: An update. Pharmacol. Biochem. Behav. 1987, 26, 463-474.
12. Shibata, M., T. Ohkubo, H. Takahashi & R. Inoki: Modified formalin test: characteristic biphasic pain response. Pain 1989, 38, 347-352.
13. +-dependent IPSP in cat and rat thalamic and hippocampal neurones. Brain Res. 1988, 448, 351-354.
14. Stoof, J. C. & J. W. Kebabian: Two dopamine receptors: biochemistry, physiology and pharmacology. Life Sci. 1984, 35, 2281-2296.
15. Tamalet, C., M. Valli, G. Jadot, E. Mesdjian & J. Vion: Dury. Antinociceptive action of picrotoxin in the mouse. Gen. Pharmacol. 1986, 17, 489-491.
16. Ticku, M. K. & G. Maksay: Convulsant depressant site of action at the allosteric benzodiazepine-GABA receptor-ionophore complex. Life Sci. 1983, 33, 2363-2375.
17. Zarrindast, M. R. & M. Djavdan: GABA-A antagonists and baclofen analgesia. Gen. Pharmacol. 1988, 19, 703-706.
18. Zarrindast, M. R. & E. Moghaddampour: Influences of dopamine agonists and antagonists on baclofen antinociception in mice. Arch int. Pharmacodyn. 1991, 309, 42-50.
19. 2 dopamine receptor activation on morphine-induced antinociception. Arch. int. Pharmacodyn. 1989, 300, 37-50.